Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAHT and Glucose Metabolism in Transgender Persons
NCT04515472Phase 1Terminated
- Sponsor
- UT Health San Antonio
- Start
- Jun 2020
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of DehydraTECH-estrogen and testosterone in gender dysphoria (GD), sponsored by UT Health San Antonio. Started Jun 2020; status: terminated.
02
Drugs
DehydraTECH-estrogentestosterone
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NCT04515472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515472.